A 59-year-old man with Crohn’s disease was being treated with infliximab administered through a central venous access device, which had been placed for long-term intermittent treatment. He presented with stable vital signs, and the physical examination was notable for cyanosis of the head, neck, upper torso, and arms.
What’s the diagnosis ?
